Modeling the Blood-Brain Barrier in a 3D triple co-culture microfluidic system

The need for a blood-brain barrier (BBB) model that accurately mimics the physiological characteristics of the in-vivo situation is well-recognized by researchers in academia and industry. However, there is currently no in-vitro model allowing studies of neuronal growth and/or function influenced by factors from the blood that cross through the BBB. Therefore, we established a 3D triple co-culture microfluidic system using human umbilical vein endothelial cells (HUVEC) together with primary rat astrocytes and neurons. Immunostaining confirmed the successful triple co-culture system consisting of an intact BBB with tight intercellular junctions in the endothelial monolayer. The BBB selective permeability was determined by a fluorescent-based assay using dextrans of different molecular weights. Finally, neuron functionality was demonstrated by calcium imaging.

[1]  L. Garcia-Segura,et al.  Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease , 2014, Front. Cell. Neurosci..

[2]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[3]  Chulhee Choi,et al.  Reliable permeability assay system in a microfluidic device mimicking cerebral vasculatures , 2012, Biomedical Microdevices.

[4]  T W Gardner,et al.  Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. , 2000, Microvascular research.

[5]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[6]  J. Flammer,et al.  Does the blood-brain barrier play a role in Glaucoma? , 2007, Survey of ophthalmology.

[7]  R. Kamm,et al.  Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.

[8]  M. Piquette-Miller,et al.  Blood–brain barrier: An impediment to neuropharmaceuticals , 2015, Clinical pharmacology and therapeutics.

[9]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[10]  Liu Cao,et al.  Increased permeability of the blood-brain barrier and Alzheimer's disease-like alterations in slit-2 transgenic mice. , 2014, Journal of Alzheimer's disease : JAD.

[11]  S. Kaech,et al.  Culturing hippocampal neurons , 2006, Nature Protocols.

[12]  G. Ming,et al.  Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital , 2015, Neurotherapeutics.

[13]  B. Fu,et al.  Non-invasive measurement of solute permeability in cerebral microvessels of the rat. , 2009, Microvascular research.